{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:28:31Z","timestamp":1761805711236,"version":"build-2065373602"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Interferon regulatory factor 2 binding protein 2 (IRF2BP2) is a transcriptional corepressor involved in immune regulation via IRF1-mediated interferon signaling inhibition. Pathogenic\n                    <jats:italic>IRF2BP2<\/jats:italic>\n                    variants are associated with common variable immunodeficiency, primarily affecting B-cell maturation. We report a 47-year-old female with immunodeficiency and systemic inflammation, including primary biliary cholangitis and unclassified arthritis, who was detected to carry a novel heterozygous\n                    <jats:italic>de novo<\/jats:italic>\n                    missense variant in the\n                    <jats:italic>IRF2BP2<\/jats:italic>\n                    gene (c.1663T&amp;gt;A; p. Cys555Ser). Immunophenotyping revealed na\u00efve B-cell predominance, with a loss of memory B cells and impaired plasmablast differentiation, indicating late-stage disturbed B-cell differentiation\/maturation. CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells demonstrated Th1 polarization with reduced Th2 subsets, whereas Th17 and Treg populations exhibited no obvious changes. Considering that IRF2BP2 negatively regulates STAT1-driven transcription via IRF1 suppression, the observed Th1 polarization suggests improved STAT1 activity. This case underscores the combined humoral and cellular immune dysregulation due to IRF2BP2 dysfunction, expanding the clinical spectrum to encompass inflammatory phenotype.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1662899","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:23:48Z","timestamp":1761805428000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Novel IRF2BP2 variant in a Japanese patient with impaired B-cell differentiation, Th1 polarization, and systemic immune dysregulation"],"prefix":"10.3389","volume":"16","author":[{"given":"Yushiro","family":"Endo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Kurushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tomokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-ichiro","family":"Yoshiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.MR1218-507R","article-title":"IRF2BP2: A new player in the regulation of cell homeostasis","volume":"106","author":"Ramalho-Oliveira","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg431","article-title":"Identification of novel co-repressor molecules for Interferon Regulatory Factor-2","volume":"31","author":"Childs","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00064-9","article-title":"CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha\/beta signaling","volume":"13","author":"Hida","year":"2000","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2896","article-title":"Identification of a novel pathway that selectively modulates apoptosis of breast cancer cells","volume":"69","author":"Tinnikov","year":"2009","journal-title":"Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn940","article-title":"The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response","volume":"37","author":"Koeppel","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaci.2016.01.018","article-title":"Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder","volume":"138","author":"Keller","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1279171","article-title":"Novel frameshift variants expand the map of the genetic defects in IRF2BP2","volume":"14","author":"Garcia-Aznar","year":"2023","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"110326","DOI":"10.1016\/j.clim.2024.110326","article-title":"Novel hypermorphic variants in IRF2BP2 identified in patients with common variable immunodeficiency and autoimmunity","volume":"266","author":"Anim","year":"2024","journal-title":"Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.jaci.2025.02.038","article-title":"IRF2BP2 deficiency: An important form of common variable immunodeficiency with inflammation","volume":"155","author":"Udemgba","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.627423","article-title":"Granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID): A multicenter retrospective study of patients from Italian PID referral centers","volume":"12","author":"Cinetto","year":"2021","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-362533","article-title":"IL-21 is the primary common gamma chain-binding cytokine required for human B-cell differentiation in vivo","volume":"118","author":"Recher","year":"2011","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/ph14080797","article-title":"IRF2BP2 mutation is associated with increased STAT1 and STAT5 activation in two family members with inflammatory conditions and lymphopenia","volume":"14","author":"Palmroth","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11434-010-0030-9","article-title":"STAT1 signaling is required for optimal Th1 cell differentiation in mice","volume":"55","author":"Ma","year":"2010","journal-title":"Chin Sci Bull"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00974-10","article-title":"Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity","volume":"31","author":"Carneiro","year":"2011","journal-title":"Mol Cell Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211110","article-title":"AP-1-independent NFAT signaling maintains follicular T cell function in infection and autoimmunity","volume":"220","author":"Seth","year":"2023","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac575","article-title":"Novel mutation and expanding phenotype in IRF2BP2 deficiency","volume":"62","author":"Korholz","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/0961203306075383","article-title":"Activation of the STAT1 signalling pathway in lupus nephritis in MRL\/lpr mice","volume":"16","author":"Dong","year":"2007","journal-title":"Lupus"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1372","article-title":"Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice","volume":"56","author":"Kim","year":"2007","journal-title":"Diabetes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41467-019-08743-8","article-title":"STAT1 signaling shields T cells from NK cell-mediated cytotoxicity","volume":"10","author":"Kang","year":"2019","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00693-5","article-title":"The link between circulating follicular helper T cells and autoimmunity","volume":"22","author":"Walker","year":"2022","journal-title":"Nat Rev Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662899\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:23:54Z","timestamp":1761805434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662899\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":20,"alternative-id":["10.3389\/fimmu.2025.1662899"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1662899","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"article-number":"1662899"}}